database_amyloid %>%
select(-study_id, -attr, -al, -ef_equal_to_and_40, -ef_more_than_40, -pts_on_farxiga, jardiance) %>%
tbl_summary(
# statistic = list(
statistic = list(
age ~ "{mean} ({sd})",
gfr ~ "{mean} ({sd})",
duration_of_sglt2i_months ~ "{mean} ({sd})"
)) %>% add_n| Characteristic | N | N = 561 |
|---|---|---|
| gender | 56 | |
| F | 17 (30%) | |
| M | 39 (70%) | |
| age | 56 | 80 (8) |
| unknown | 56 | 4 (7.1%) |
| ef | 52 | 50 (36, 55) |
| Unknown | 4 | |
| dm | 56 | 19 (34%) |
| ckd_stage_less_than_3a | 56 | 28 (50%) |
| ckd_stage_equal_to_or_more_than_3a | 56 | 28 (50%) |
| ckd_stage | 56 | |
| stage 1 | 2 (3.6%) | |
| stage 2 | 25 (45%) | |
| Stage 2 | 1 (1.8%) | |
| stage 3A | 13 (23%) | |
| stage 3B | 11 (20%) | |
| stage 4 | 4 (7.1%) | |
| gfr | 56 | 58 (18) |
| pro_bnp_at_the_time_of_initiation_of_therapy_pg_m_l | 17 | 1,742 (1,060, 5,116) |
| Unknown | 39 | |
| pro_bnp_following_initiation_of_sglt2i | 16 | 1,446 (829, 2,762) |
| Unknown | 40 | |
| duration_of_sglt2i_months | 55 | 19 (9) |
| Unknown | 1 | |
| jardiance | 56 | 50 (89%) |
| sglt2i_dced | 3 | |
| jardiance dc'ed due to complicated UTI | 1 (33%) | |
| jardiance dc'ed since hospice | 1 (33%) | |
| Jardiance was dc'ed- no reason | 1 (33%) | |
| Unknown | 53 | |
| gdmt | 56 | 51 (91%) |
| complication_aki_following_sglt2i | 56 | 3 (5.4%) |
| complication_uti | 56 | 2 (3.6%) |
| complication_simple_depletion | 56 | 1 (1.8%) |
| complication_hospitalization_for_chf | 56 | 6 (11%) |
| sglt2_medication | 56 | |
| farxiga | 6 (11%) | |
| jardiance | 50 (89%) | |
| amyloid_type | 56 | |
| al | 3 (5.4%) | |
| attr | 53 (95%) | |
| ef_cutoff | 52 | |
| ef_less_40 | 15 (29%) | |
| ef_more_or_equal_40 | 37 (71%) | |
| Unknown | 4 | |
| 1 n (%); Mean (SD); Median (IQR) | ||
database_amyloid %>%
filter(amyloid_type=="attr") %>%
select(-study_id, -attr, -al, -ef_equal_to_and_40, -ef_more_than_40, -pts_on_farxiga, jardiance) %>%
tbl_summary(
statistic = list(
age ~ "{mean} ({sd})",
gfr ~ "{mean} ({sd})",
duration_of_sglt2i_months ~ "{mean} ({sd})"
)) %>% add_n| Characteristic | N | N = 531 |
|---|---|---|
| gender | 53 | |
| F | 15 (28%) | |
| M | 38 (72%) | |
| age | 53 | 81 (8) |
| unknown | 53 | 4 (7.5%) |
| ef | 49 | 50 (36, 55) |
| Unknown | 4 | |
| dm | 53 | 17 (32%) |
| ckd_stage_less_than_3a | 53 | 26 (49%) |
| ckd_stage_equal_to_or_more_than_3a | 53 | 27 (51%) |
| ckd_stage | 53 | |
| stage 1 | 2 (3.8%) | |
| stage 2 | 23 (43%) | |
| Stage 2 | 1 (1.9%) | |
| stage 3A | 13 (25%) | |
| stage 3B | 10 (19%) | |
| stage 4 | 4 (7.5%) | |
| gfr | 53 | 58 (18) |
| pro_bnp_at_the_time_of_initiation_of_therapy_pg_m_l | 17 | 1,742 (1,060, 5,116) |
| Unknown | 36 | |
| pro_bnp_following_initiation_of_sglt2i | 16 | 1,446 (829, 2,762) |
| Unknown | 37 | |
| duration_of_sglt2i_months | 53 | 19 (9) |
| jardiance | 53 | 47 (89%) |
| sglt2i_dced | 3 | |
| jardiance dc'ed due to complicated UTI | 1 (33%) | |
| jardiance dc'ed since hospice | 1 (33%) | |
| Jardiance was dc'ed- no reason | 1 (33%) | |
| Unknown | 50 | |
| gdmt | 53 | 49 (92%) |
| complication_aki_following_sglt2i | 53 | 2 (3.8%) |
| complication_uti | 53 | 2 (3.8%) |
| complication_simple_depletion | 53 | 1 (1.9%) |
| complication_hospitalization_for_chf | 53 | 6 (11%) |
| sglt2_medication | 53 | |
| farxiga | 6 (11%) | |
| jardiance | 47 (89%) | |
| amyloid_type | 53 | |
| attr | 53 (100%) | |
| ef_cutoff | 49 | |
| ef_less_40 | 14 (29%) | |
| ef_more_or_equal_40 | 35 (71%) | |
| Unknown | 4 | |
| 1 n (%); Mean (SD); Median (IQR) | ||
create_table <- function(data) {
}